Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1976-09-01
1979-05-01
Sebastian, Leland A.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
23230B, 424 12, 424 85, 424 88, A61K 4300
Patent
active
041524101
ABSTRACT:
NEA (Neoplasm embryonic antigen) and NEA antibody; diagnosis reagents for neoplasm comprising a substance selected from the group consisting of NEA antibody, NEA or NEA antibody labelled with a radioactive isotope, a combined product of NEA or NEA antibody with a particulate substance, a gel plate containing NEA antibody, and a carbamylated NEA antibody; methods for the diagnosis of neoplasm; processes for the production of NEA antibody; and methods for the purification of NEA and NEA antibody. The reagents are very useful for the diagnosis of neoplasms.
REFERENCES:
patent: 3663684 (1972-05-01), Freedman et al.
patent: 3697638 (1972-10-01), Hansen
patent: 3852415 (1974-12-01), Vandervoorde
patent: 3867363 (1975-02-01), Hansen
patent: 3927193 (1975-12-01), Hansen et al.
patent: 3960827 (1976-06-01), Bjorklund
Eisai Co. Ltd.
Sebastian Leland A.
LandOfFree
Diagnosis reagent for neoplasm and method for diagnosis of neopl does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Diagnosis reagent for neoplasm and method for diagnosis of neopl, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diagnosis reagent for neoplasm and method for diagnosis of neopl will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-631624